{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:56:09Z","timestamp":1791968169127,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thesurgeon.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Surgeon"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.surge.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T07:46:11Z","timestamp":1396079171000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Increasing trend of contralateral prophylactic mastectomy: What are the factors behind this phenomenon?"],"prefix":"10.1016","volume":"12","author":[{"given":"Atilla","family":"Soran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayfer","family":"Kamali Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandace P.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surge.2014.02.005_bib1","series-title":"Cancer facts & figures","year":"2013"},{"issue":"33","key":"10.1016\/j.surge.2014.02.005_bib2","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","article-title":"Increasing use of contralateral prophylactic mastectomy for breast Cancer patients: a trend toward more aggressive surgical treatment","volume":"25","author":"Tuttle","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.surge.2014.02.005_bib3","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1245\/s10434-010-1091-3","article-title":"Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998\u20132007","volume":"17","author":"Yao","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.surge.2014.02.005_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1245\/s10434-006-9264-9","article-title":"Is routine Sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience","volume":"14","author":"Soran","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.surge.2014.02.005_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10549-006-9423-5","article-title":"Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors","volume":"104","author":"Graves","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.surge.2014.02.005_bib6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/cncr.24129","article-title":"Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy","volume":"115","author":"Yi","year":"2009","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.surge.2014.02.005_bib7","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1245\/s10434-009-0641-z","article-title":"Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer","volume":"16","author":"Arrington","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.surge.2014.02.005_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.surge.2014.02.005_bib9","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2001.19.19.3938","article-title":"Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer","volume":"19","author":"McDonnell","year":"2001","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.surge.2014.02.005_bib10","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/cncr.20617","article-title":"Contralateral prophylactic mastectomy. Predictors of significant histologic findings","volume":"101","author":"Goldflam","year":"2004","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.surge.2014.02.005_bib11","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2009.27.6774","article-title":"Are mastectomy rates really increasing in the United States?","volume":"28","author":"Habermann","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.surge.2014.02.005_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/djq018","article-title":"Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients","volume":"102","author":"Bedrosian","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.surge.2014.02.005_bib13","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1245\/s10434-009-0362-3","article-title":"Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy","volume":"16","author":"Sorbero","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.surge.2014.02.005_bib14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1940-6207.CAPR-09-0130","article-title":"Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy","volume":"3","author":"Yi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"22","key":"10.1016\/j.surge.2014.02.005_bib15","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1002\/cncr.27574","article-title":"Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status","volume":"118","author":"Brewster","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.surge.2014.02.005_bib16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1200\/JCO.2007.12.6078","article-title":"Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the hereditary breast cancer clinical study group","volume":"26","author":"Metcalfe","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.surge.2014.02.005_bib17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/bjc.2011.120","article-title":"Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"104","author":"Metcalfe","year":"2011","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.surge.2014.02.005_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejso.2011.12.014","article-title":"Increasing rates of contralateral prophylactic mastectomy \u2013 a trend made in USA?","volume":"38","author":"Guth","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"25","key":"10.1016\/j.surge.2014.02.005_bib19","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1200\/JCO.2008.19.4225","article-title":"Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging","volume":"27","author":"Katipamula","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.surge.2014.02.005_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9610(00)00505-5","article-title":"Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer","volume":"180","author":"Peralta","year":"2000","journal-title":"Am J Surg"},{"key":"10.1016\/j.surge.2014.02.005_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0b013e318292f8a7","article-title":"Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast Cancer","author":"Soran","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"10.1016\/j.surge.2014.02.005_bib22","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1245\/s10434-012-2525-x","article-title":"Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age","volume":"19","author":"Fisher","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.surge.2014.02.005_bib23","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1245\/s10434-013-3116-1","article-title":"Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database","volume":"20","author":"Osman","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.surge.2014.02.005_bib24","first-page":"CD002748","article-title":"Prophylactic mastectomy for the prevention of breast cancer","volume":"18","author":"Lostumbo","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.surge.2014.02.005_bib25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","article-title":"Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ","volume":"27","author":"Tuttle","year":"2009","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.surge.2014.02.005_bib26","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/JCO.2005.01.910","article-title":"Contralateral breast cancer: where does it all begin?","volume":"23","author":"Wedam","year":"2005","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.surge.2014.02.005_bib27","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.2005.04.3273","article-title":"Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials","volume":"24","author":"Wapnir","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.surge.2014.02.005_bib28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.surge.2014.02.005_bib29","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","article-title":"Contralateral breast cancer in BRCA1 and\u00a0BRCA2 mutation carriers","volume":"22","author":"Metcalfe","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.surge.2014.02.005_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-013-2583-1","article-title":"Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer","volume":"140","author":"Evans","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.surge.2014.02.005_bib31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1586\/14737140.7.8.1117","article-title":"Contralateral prophylactic mastectomy for patients with unilateral breast cancer","volume":"7","author":"Tuttle","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"10.1016\/j.surge.2014.02.005_bib32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0039-6060(05)80030-3","article-title":"Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer","volume":"118","author":"Lee","year":"1995","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.surge.2014.02.005_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01807886","article-title":"The surgeon's role in breast cancer: changing concepts","volume":"1","author":"Leis","year":"1981","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.surge.2014.02.005_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10434-999-0542-1","article-title":"Issues of regret in women with contralateral prophylactic mastectomies","volume":"6","author":"Montgomery","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surge.2014.02.005_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1524-4741.1997.tb00133.x","article-title":"The role of contralateral prophylactic mastectomy in invasive lobular carcinoma","volume":"3","author":"Babiera","year":"1997","journal-title":"Breast J"},{"issue":"1","key":"10.1016\/j.surge.2014.02.005_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Forbes","year":"2008","journal-title":"Lancet Oncol"},{"issue":"9132","key":"10.1016\/j.surge.2014.02.005_bib37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(98)03301-7","article-title":"Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group","volume":"352","author":"Group EBCTC","year":"1998","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.surge.2014.02.005_bib38","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1200\/JCO.2002.11.101","article-title":"Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less","volume":"20","author":"Fisher","year":"2002","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.surge.2014.02.005_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jama.283.5.617","article-title":"Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations","volume":"283","author":"Schrag","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.surge.2014.02.005_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6602703","article-title":"Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers","volume":"93","author":"Van Sprundel","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surge.2014.02.005_bib41","series-title":"Breast cancer screening and diagnosis","year":"2012"},{"key":"10.1016\/j.surge.2014.02.005_bib42","series-title":"Breast cancer risk reduction","year":"2012"}],"container-title":["The Surgeon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X14000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X14000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:55:26Z","timestamp":1565315726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1479666X14000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1479666X14000201"],"URL":"https:\/\/doi.org\/10.1016\/j.surge.2014.02.005","relation":{},"ISSN":["1479-666X"],"issn-type":[{"value":"1479-666X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing trend of contralateral prophylactic mastectomy: What are the factors behind this phenomenon?","name":"articletitle","label":"Article Title"},{"value":"The Surgeon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surge.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}